(MedPage Today) — Researchers for the ongoing 30-year Diabetes Prevention Program found out last week that the NIH canceled funding for the project. (Independent)
Gender-affirming hormone therapy was associated with a lower risk of moderate-to…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/114712
Author :
Publish date : 2025-03-18 17:38:00
Copyright for syndicated content belongs to the linked Source.